A type of medication that lowers blood glucose by causing glucose loss in the urine may protect against a painful joint condition called gout. Among nearly 300,000 adults with type 2 diabetes in a U.S. insurance database, those taking an oral SGLT-2 inhibitor had a 40 percent lower risk for developing gout than those taking a different type of glucose-lowering medication. The condition, a form of arthritis, results in sudden pain, swelling, and redness in the joints, often around the big toe. It’s more common in people with type 2 diabetes. Further studies are needed to see whether SGLT-2 inhibitors directly prevent gout, but if gout runs in your family, limiting your intake of alcohol, fatty foods, and meats may reduce your risk.
Source: Annals of Internal Medicine, published online Jan. 13, 2020